Stem cell-based therapies for cancer treatment: separating hope from hype

feature-image

Play all audios:

Stem cell-based therapies are emerging as a promising strategy to tackle cancer. Multiple stem cell types have been shown to exhibit inherent tropism towards tumours. Moreover, when


engineered to express therapeutic agents, these pathotropic delivery vehicles can effectively target sites of malignancy. This perspective considers the current status of stem cell-based


treatments for cancer and provides a rationale for translating the most promising preclinical studies into the clinic.


The authors apologize to all colleagues whose work could not be cited owing to space limitations. This work was supported by grants R01CA138922, R01CA173077, and the James S. McDonnell


Foundation.


Molecular Neurotherapy and Imaging Laboratory and the Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, 02114, Massachusetts, USA


Molecular Neurotherapy and Imaging Laboratory and the Departments of Radiology and Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA,


and the Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts 02138, USA.,


Anyone you share the following link with will be able to read this content: